WESTPHAL CHRISTOPH H purchased 11.6% of their position (133.33K shares) of TSCAN THERAPEUTICS, INC. on the open market
Open‑market purchase worth $2.00M — a moderate purchase. The strongest form of insider conviction signal.
Voting Common Stock
Shares
+1.15M
Price / share
—
Trade value
—
% of position
Voting Common Stock
Shares
+133.33K
Price / share
$15.00
Trade value
$2M
% of position
Net shares
+1.28M
Net value
$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Voting Common Stock Indirect | 7/20/2021 | C · Conversion | +1.15M | — | — | New position | 0.00 | 1.15M |
| Voting Common Stock Indirect | 7/20/2021 | P · Purchase | +133.33K | $15.00 | $2M | 11.6% | 1.15M | 1.28M |
| Total | +1.28M | $2M | ||||||
Series A Preferred Stock
Voting Common Stock
641.85K shares
Shares
−641.85K
Strike price
Held after
0.00
Exercisable
—
Series B Preferred Stock
Voting Common Stock
332.59K shares
Shares
−332.59K
Strike price
Held after
0.00
Exercisable
—
Series C Preferred Stock
Voting Common Stock
171.06K shares
Shares
−171.06K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Voting Common Stock641.85K shares | 7/20/2021 | C · Conversion | −641.85K | — | 0.00 | |
| Series B Preferred Stock Indirect | Voting Common Stock332.59K shares | 7/20/2021 | C · Conversion | −332.59K | — | 0.00 | |
| Series C Preferred Stock Indirect | Voting Common Stock171.06K shares | 7/20/2021 | C · Conversion | −171.06K | — | 0.00 |
Voting Common Stock
IndirectVoting Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Voting Common Stock | 121.95K | Indirect |
| Voting Common Stock | 914.63K | Direct |
| Total | 1.04M | 914.63K direct·121.95K indirect |